Board of Directors
Lou Panaccio - Chairman
Mr Panaccio was appointed Chairman of the Board 1 July 2014. Lou has more than 30 years of executive leadership experience in the life sciences and health services, including 15 years board-level experience. He is currently a Non-Executive Director of one of the world's largest medical diagnostics companies, ASX50-listed Sonic Healthcare Limited, where he has serviced since 2005. In addition, Mr Panaccio is the Executive Chairman of Health Networks Australia Group, Non-Executive Director Yarra Community Housing, Non-Executive Director Inner East Community Health Service and Executive Chairman of Genera Biosystems Limited. His previous roles included Chief Executive Officer and Executive Director of Melbourne Pathology, as well as executive and board roles with CPW Group, Monash IVF Group, Primelife Corporation and other private entities.
Jeremy Curnock Cook - Non-executive Director
Mr. Curnock Cook was appointed to the Board on 19 October 2012. Jeremy has served as Chairman of International Bioscience Managers Limited, a corporate and investment advisory firm since 2000, and also currently serves as a director of Excalibur Group Holdings Ltd., a medical sciences investment house. Mr. Curnock Cook is currently on a number of boards of international healthcare and biotechnology companies. Jeremy is the former head of the life science private equity team at Rothschild Asset Management, was responsible for the launch of the first dedicated biotechnology fund for the Australian market and the launch of a joint venture with Johnson & Johnson Development Corporation for the creation of Healthcare Ventures, an investment vehicle dedicated to seed stage investments in Europe, as well as the conception and launch of the International Biotechnology Trust (IBT). Mr. Curnock Cook holds a M.A. in Natural Sciences from Trinity College, Dublin.
Ian Macpherson - Non-executive Director
Mr Macpherson was appointed to the Board on 5 March 2008 following completion of the merger with Visiomed Group Limited. Mr Macpherson is a graduate from the University of Western Australia with a Bachelor of Commerce (B.Comm). He commenced his career in commerce in 1978 prior to entering the Chartered Accounting profession. In July 1990 he resigned from the partnership of Arthur Anderson and Co to establish the firm of Ord Partners, Chartered Accountants.
Mr Macpherson advises on capital structuring, equity and debt raising, ASIC and Securities Exchange compliance procedures. He is a member of the Institute of Chartered Accountants in Australia. Mr Macpherson is also a director of other listed companies including Navigator Resources Limited and Nimrodel Resources Limited.
Matt McNamara - Non-executive Director
Mr. McNamara was appointed to the Board on 19 October 2012. Matt is currently the Chief Investment Officer and Fund Manager of Bioscience Managers Pty Ltd. He has over 25 years of experience in the healthcare & medical sciences sector. Matt initially worked in molecular biology research and spent 11 years in Sales & Marketing and General Management with Merck & Co. and Johnson & Johnson Medical Pty. Ltd. He has served as SVP Business Development for eBioinformatics Inc., and was CEO of a Life Sciences Venture Capital fund, SciCapital Pty. Ltd.
Dr. Michael S. Perry Ph.D - Non-executive Director
Dr. Perry was appointed to the Board on 6th of February 2013. He currently serves as Vice President and Senior Global Program Head, Stem Cell Therapy at Novartis Pharmaceuticals Corp. Based in the US and with over 25 years of successful pharmaceutical/biotech management and development experience, Dr. Perry previously served as the Global Head of R&D at Baxter Healthcare; President, Cell & Gene Therapy at Novartis affiliates SyStemix and Genetic Therapy, Inc.; VP Regulatory Affairs at Sandoz Pharmaceuticals Corp; Director of Regulatory Affairs at Schering-Plough Corporation; and Chairman, CEO or CMO at several early stage biotech companies. From 2005 to 2012, Dr. Perry was a Venture Partner with Bay City Capital, a California-based venture capital firm managing over US$1.6 billion invested predominantly in life science companies. Dr. Perry holds a Doctor of Veterinary Medicine, Ph.D. in Biomedical Pharmacology and a B.Sc. in Physics from the University of Guelph, Ontario, Canada. He is a graduate of the International Management Program at Harvard Business School.
Fiona Wood - Non-executive Director
Clinical Professor Wood was re-appointed to the Board on 11 April 2006 following her earlier resignation from the Board on 31 December 2005. Professor Wood is currently Director of the Western Australian Burns Service and a Consultant Plastic Surgeon at both the Royal Perth and Princess Margaret hospitals. She is the Chairman of the McComb Research Foundation established in 1999 with co-founder Marie Stoner.
Clinical Professor Wood has been involved in a number of education and disaster response programs associated with her interest in burns and has published a variety of papers over the years. In addition, she has been the recipient of the 2003 Australian Medical Association "Contribution to Medicine" award and an Order of Australia Medal for her work with Bali bombing victims.
Professor Wood was named West Australian of the Year in 2004 and 2005 and was named as Australian of the Year in 2005.